Log in

View Full Version : General Cancer News


Pages : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56

  1. Breast cancer survivors could avoid lifelong heart medication, research suggests (0 replies)
  2. Study shows how cancer can act as a systemic disease (0 replies)
  3. Cell proliferation gene plays a distinct role in cells that no longer proliferate (0 replies)
  4. New discovery paves way for highly personalized breast cancer therapies (0 replies)
  5. Biosimilars reduce financial burden for cancer patients and insurers (0 replies)
  6. UMass Amherst researcher wins $2.5 million to expand nanoparticle cancer vaccine stu (0 replies)
  7. Study challenges traditional breast cancer classification methods (0 replies)
  8. Study tracks global patterns and socioeconomic inequalities in the burden of breast c (0 replies)
  9. Standard memory tests fail to detect post-chemotherapy brain fog (0 replies)
  10. What decades of wine research can, and cannot, tell us about health (0 replies)
  11. Targeting cyclin-dependent kinases offers new pathways for cancer therapy (0 replies)
  12. A striking immune cell pattern emerges around a person?s 100th birthday (0 replies)
  13. Australian researchers uncover a promising new way to tackle triple-negative breast c (0 replies)
  14. Multifunctional nanoplatform addresses three key barriers to effective TNBC immunothe (0 replies)
  15. Scientists identify molecule driving one of the deadliest forms of breast cancer (0 replies)
  16. Scientists uncover safer way to tame cancer cell senescence (0 replies)
  17. Multi-organ chip uncovers key mechanisms behind cancer metastasis (0 replies)
  18. Special journal issue highlights precision prevention in cancer epidemiology (0 replies)
  19. Red blood cells inspire next-generation therapeutic nanocarriers (0 replies)
  20. Dual-action compounds show promise against aggressive cancer and infections (0 replies)
  21. Alliance highlights the importance of clinical research on World Breast Cancer Resear (0 replies)
  22. Engineered red blood cell vesicles improve gene therapy delivery (0 replies)
  23. Aircrews face highest risk of radiation-related cancer deaths (0 replies)
  24. Regional chemotherapy differences may impact survival among older breast cancer patie (0 replies)
  25. Preoperative combination therapy improves head and neck cancer outcomes (0 replies)
  26. 'Locked' cancer therapeutic safely shrinks breast tumors in mice (0 replies)
  27. Mitochondrial gene RTN4IP1 drives triple-negative breast cancer metastasis (0 replies)
  28. Study: Nearly all personal care and cleaning products contain undisclosed chemicals (0 replies)
  29. Genetic tool turns soft cancer cells into immune targets (0 replies)
  30. Lab-grown mini tumors help scientists predict breast cancer treatment success (0 replies)
  31. Thinning cancer cells' sugar coating could expose tumors to immune attack (0 replies)
  32. Two-gene interaction reveals metastatic risk in breast cancer (0 replies)
  33. Tuft cell-like cancers across multiple organs exhibit unique biological characteristi (0 replies)
  34. Digital care app improves quality of life for breast cancer patients (0 replies)
  35. Experimental drug CS18 shows promise for overcoming cancer treatment resistance (0 replies)
  36. Expanded DepMap reveals new cancer vulnerabilities through 3D tumor models (0 replies)
  37. Tumor-secreted protein makes lung blood vessels leaky to promote metastasis (0 replies)
  38. Novel drug puts cancer cells under extreme metabolic stress (0 replies)
  39. NIH funds research to explore the role of thymulin in inflammaging and cancer (0 replies)
  40. Breast cancer co-opts the immune system to attract nerves that fuel tumor growth (0 replies)
  41. Current NICE criteria miss most younger women at breast cancer risk (0 replies)
  42. Scientists map protective cell networks hiding dormant breast tumor cells (0 replies)
  43. Exposure to fungicides and insecticides alters onset of puberty in girls (0 replies)
  44. Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2- (0 replies)
  45. Low-fat diet lowers dietary glycation compounds for years in postmenopausal women (0 replies)
  46. New cancer vaccine harnesses COVID-19 immune memory to fight tumors (0 replies)
  47. Engineered extracellular vesicles dramatically improve cancer detection sensitivity (0 replies)
  48. Thymulin curbs age-related inflammation and slows breast tumors in mice (0 replies)
  49. DNA enhancer hubs control cancer genes in prostate tumors (0 replies)
  50. Common heart risk calculators effectively predict certain types of cancer (0 replies)
  51. New target makes cancer cells vulnerable to immune destruction (0 replies)
  52. G&H highlights end-to-end diagnostic device development at ADLM 2026 (0 replies)
  53. LIG1 loss reveals new treatment strategy for aggressive breast cancer (0 replies)
  54. New model improves short- and long-term disease risk prediction (0 replies)
  55. Weill Cornell Medicine receives DoD grant to target triple-negative breast cancer (0 replies)
  56. Study highlights breast screening barriers facing Black women in Britain (0 replies)
  57. Bile acid buildup linked to aggressive breast cancer progression (0 replies)
  58. Self-assembling antibody drugs successfully target multiple cancer receptors (0 replies)
  59. Targeted nanoparticles destroy tumor cells by triggering cuproptosis (0 replies)
  60. Breast and prostate cancer survival worsens with metabolic syndrome (0 replies)
  61. Combination treatment strategy uses cells' waste removal functions to dismantle multi (0 replies)
  62. Global hotspots where breast cancer and atrial fibrillation overlap (0 replies)
  63. Global cancer cases projected to reach nearly 35 million by 2050 (0 replies)
  64. Yeast food supplement helps immune cells fight cancer more effectively (0 replies)
  65. Researchers at Tulane University School of Medicine strengthen breast cancer research (0 replies)
  66. Researchers at Tulane University School of Medicine strengthen breast cancer research (0 replies)
  67. Toronto researchers uncover genetic drivers of triple negative breast cancer (0 replies)
  68. New study identifies shared risk factors for breast cancer and atrial fibrillation (0 replies)
  69. Sexual and gender minority populations are less likely to receive cancer screening (0 replies)
  70. New nonhormonal therapy shows promise for treating Genitourinary Syndrome of Menopaus (0 replies)
  71. Phenolic compounds linked to precocious puberty or early breast development in girls (0 replies)
  72. Estonian study highlights value of early genetic tests to identify hereditary cancer (0 replies)
  73. FDA approves new therapy for double-positive metastatic breast cancer (0 replies)
  74. Persistent disparities found in preventive cancer care for sexual and gender minority (0 replies)
  75. New breast cancer classification system predicts immunotherapy response success (0 replies)
  76. Flavonoid-rich foods may blunt breast cancer risk tied to genetics (0 replies)
  77. Reversing macrophage metabolism may improve cancer immunotherapy outcomes (0 replies)
  78. New portable ultrasound device enhances breast cancer screening accuracy (0 replies)
  79. German study identifies therapeutic Achilles' heel for advanced colorectal cancer (0 replies)
  80. Obesity drives distinct molecular pathway toward invasive breast cancer (0 replies)
  81. Scientists map how cellular senescence and stemness interact in disease (0 replies)
  82. Multi-decade study tracks subsequent cancer risks in survivors (0 replies)
  83. Artificial intelligence improves diagnostic accuracy in clinical breast pathology (0 replies)
  84. Gut microbes emerge as potential players in estrogen-driven cancers (0 replies)
  85. Lipid nanoparticles enhance immune response against lung cancer (0 replies)
  86. New diagnostic platform enables automated HER2 scoring of breast cancer tissue sample (0 replies)
  87. FDA approves palbociclib combination for advanced HR-positive HER2-positive breast ca (0 replies)
  88. Microbes trigger cell death to boost cancer immunotherapy effectiveness (0 replies)
  89. Eating 90 g of wholegrains daily linked to lower breast cancer risk (0 replies)
  90. Scientists unlock molecular structure of key protein linked to cancer, neurological d (0 replies)
  91. AI image-based risk scores enable dynamic breast cancer assessment (0 replies)
  92. Scientists discover how fat tissue drives the spread of triple-negative breast cancer (0 replies)
  93. Keck School of Medicine of USC and Novartis collaborate to eliminate breast cancer sc (0 replies)
  94. Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy (0 replies)
  95. Mount Sinai study connects social determinants of health to disease risks (0 replies)
  96. Researchers advocate local data strategies for early cancer detection (0 replies)
  97. New human protein atlas maps how cancer rewires the body?s tissues (0 replies)
  98. New method generates renewable supply of progenitor immune cells (0 replies)
  99. Insilico Medicine to showcase AI-driven drug breakthroughs at BIO 2026 International (0 replies)
  100. Preoperative radiation boosts immunotherapy response in brain metastases (0 replies)
  101. Researchers at Tulane University School of Medicine strengthen breast cancer research (0 replies)
  102. Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer lin (0 replies)
  103. Universities and hospitals repurpose existing drugs at significantly lower costs (0 replies)
  104. Semaglutide, omega-3s and diet shift epigenetic aging clocks in human studies (0 replies)
  105. Neutrophils reduce the effectiveness of cancer immunotherapy in mice (0 replies)
  106. Light-controlled molecular switch wakes lung cancer cells for treatment (0 replies)
  107. Novel analysis identifies unique proliferation gene alterations in diverse cancer pat (0 replies)
  108. Novel metal-free prodrug suppresses cancer spread in preclinical models (0 replies)
  109. Review outlines virtual tumor concept and next-generation immunotherapy (0 replies)
  110. Researchers isolate intact tumor microRNAs using antibody-conjugated nanowires (0 replies)
  111. One drink a day may be the new upper limit for safer alcohol guidance (0 replies)
  112. Machine learning model filters out the biological noise in liquid biopsy samples (0 replies)
  113. Radiology AI systems flag breast cancer signs six years before diagnosis (0 replies)
  114. Brain-targeted estrogen reduces breast cancer treatment side effects (0 replies)
  115. DNA study links BRCA genes to aggressive early-onset breast cancer in black women (0 replies)
  116. Review highlights TIGIT as a promising second-generation immunotherapy target (0 replies)
  117. Study reveals how breast cancer cells hide in the bone marrow (0 replies)
  118. Could GLP-1 drugs help prevent breast cancer? New study points to a possible link (0 replies)
  119. New AI tool cuts breast cancer biopsy wait times (0 replies)
  120. City of Hope sets new standard for lifelong, research-driven cancer survivorship care (0 replies)
  121. GLP-1 medications linked to lower breast cancer risk in women (0 replies)
  122. Genetic testing finds breast cancer risks that standard screening models miss (0 replies)
  123. Study evaluates statistical models for estimating breast cancer risk (0 replies)
  124. Millions live with undiagnosed heart rhythm disorders ? World Heart Rhythm Week 2026 (0 replies)
  125. Gene test helps many breast cancer patients avoid chemotherapy (0 replies)
  126. Survey reveals critical knowledge gaps in maternal health recommendations (0 replies)
  127. Obesity alters tumor environment promoting invasive breast cancer growth (0 replies)
  128. How common spices may improve gut, brain, and metabolic health (0 replies)
  129. Current-free wireless fields selectively alter immune and cancer cell migration (0 replies)
  130. Blocking sugar modification could boost breast cancer immunotherapy success (0 replies)
  131. Study unravels mystery about why physical forces slow cancer growth (0 replies)
  132. Smaller tetraploid cells drive more aggressive cancer (0 replies)
  133. Roswell Park scientists present five key cancer studies at clinical meeting (0 replies)
  134. Researchers link surgical weight loss to reduced female cancer mortality rates (0 replies)
  135. Targeting lipid enzymes triggers starvation states in aggressive tumor cells (0 replies)
  136. Explainable AI could make breast cancer drug predictions safer and clearer (0 replies)
  137. Excess EXO1 protein may drive cancer DNA damage and treatment response (0 replies)
  138. Light-driven nanomotors improve multimodal breast cancer treatment efficacy (0 replies)
  139. Spatial modeling of tissue compartments predicts breast cancer treatment response (0 replies)
  140. Study reveals cellular mechanisms driving resistance to targeted cancer therapies (0 replies)
  141. Vitamin D deficiency linked to higher postoperative breast cancer pain (0 replies)
  142. Molecular profiling initiative seeks to uncover late breast cancer recurrence mysteri (0 replies)
  143. Common allergy medication may also help fight aggressive cancers (0 replies)
  144. Young cancer survivors frequently report long-term sexual problems (0 replies)
  145. DNA-guided CRISPR system targets RNA and expands Cas12 beyond gene editing (0 replies)
  146. Blood test detects tumor DNA to guide advanced cancer treatment (0 replies)
  147. Research offers clearer genetic blueprint of breast cancer variants (0 replies)
  148. Targeted radiotherapy may delay progression in metastatic breast cancer patients (0 replies)
  149. Study reveals why aging makes the body more vulnerable to breast cancer (0 replies)
  150. How exercise influences cancer cell viability (0 replies)
  151. Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity (0 replies)
  152. Gene panel predicts chemotherapy response in triple-negative breast cancer (0 replies)
  153. Adult weight gain strongly linked to higher obesity-related cancer risk (0 replies)
  154. Could GLP-1 drugs help breast cancer patients live longer? (0 replies)
  155. Cedars-Sinai develops AI tool for faster and cheaper tumor analysis (0 replies)
  156. New study reveals how slow-growing cells drive breast cancer relapse (0 replies)
  157. Copper-based nanoplatform shows promise against metastatic tumor growth (0 replies)
  158. The power of organoids in speeding up lifesaving drug development (0 replies)
  159. Chromosome abnormalities may help cancer cells resist treatment and spread (0 replies)
  160. Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms (0 replies)
  161. The importance of genetic screening for all cancer survivors (0 replies)
  162. Blood-based biomarkers identified for early inflammatory breast cancer diagnosis (0 replies)
  163. Hand-held wireless probe helps surgeons identify breast cancer tumors (0 replies)
  164. Researchers leverage tamoxifen's active metabolite to improve breast cancer preventio (0 replies)
  165. Extracellular vesicles from T cells enhance tumor immune response (0 replies)
  166. Liquid biopsy predicts immune response in high-risk breast cancer patients (0 replies)
  167. AI and CRISPR technologies drive proactive health monitoring (0 replies)
  168. Survey shows women are confused about when to start mammograms (0 replies)
  169. How cost, access, and awareness barriers are slowing BRCA testing (0 replies)
  170. UIC researchers develop anti-cancer therapy inspired by bacteria in tumors (0 replies)
  171. New optical imaging tool allows real-time breast cancer staging (0 replies)
  172. Baylor researchers develop SAMENT method to map metastatic tumor niches (0 replies)
  173. Estrogen loss after menopause impacts heart health through gene regulation (0 replies)
  174. New strategy boosts natural killer cells to fight cancer (0 replies)
  175. New model improves detection of Li-Fraumeni Syndrome risk (0 replies)
  176. Cell squeezing technology offers new breast cancer risk assessment (0 replies)
  177. APOLLO AI learns from 25 billion medical events to predict future disease (0 replies)
  178. Can exercise or ibuprofen fight chemo brain? (0 replies)
  179. Experimental drug kills aggressive breast cancer by toxic fat buildup (0 replies)
  180. Prostate cancer overdiagnosis risk increases substantially in older men (0 replies)
  181. Why do the deadliest cancers still get less NIH research funding? (0 replies)
  182. Chronic wildfire smoke exposure may raise long-term cancer risks (0 replies)
  183. Long-term exposure to air pollution (PM2.5) raises risk of developing cancer by 11 % (0 replies)
  184. Multimodal AI improves prediction of PIK3CA mutations in breast cancer (0 replies)
  185. AI improves imaging pathology and treatment decisions in breast cancer (0 replies)
  186. Targeting glutamine metabolism enhances CAR-macrophage cancer therapy (0 replies)
  187. Metastatic cells can be identified within primary breast tumors (0 replies)
  188. Generative AI may help scientists connect the many layers of cancer (0 replies)
  189. ACP recommends biennial mammography for women aged 50 to 74 (0 replies)
  190. Scientists find unexpected immune pathways for mRNA cancer vaccines (0 replies)
  191. New imager separates UV and infrared light to find cancerous nodes (0 replies)
  192. Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus (0 replies)
  193. Scientists discover BRCA links to head and neck cancer risks (0 replies)
  194. Higher stress and BMI tied to earlier puberty in girls (0 replies)
  195. New grant funds AI search for genetic targets to treat Alzheimer's (0 replies)
  196. VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics (0 replies)
  197. Steroid hormones, BMI and stress influence puberty timing in girls (0 replies)
  198. Clinical trial tests laser therapy for vaginal dryness in breast cancer survivors (0 replies)
  199. Young cancer survivors face double the risk of later cancers (0 replies)
  200. Weight gain timing affects long-term health outcomes (0 replies)
  201. New project aims to improve aggressive breast cancer diagnosis (0 replies)
  202. Pseudogene lncRNAs regulate cancer stem cell behavior and signaling (0 replies)
  203. Damon Runyon supports young scientists driving cancer research innovation (0 replies)
  204. Nanomedicine offers targeted solutions for breast cancer treatment (0 replies)
  205. Talc not contaminated with asbestos shows no link to cancer (0 replies)
  206. Large US study finds never-married adults face higher risk for most major cancers (0 replies)
  207. OICR funds four Ontario teams to develop next-generation cancer therapies (0 replies)
  208. Sponge and sea slug partnership yields a new anticancer molecule with drug design pro (0 replies)
  209. Dual perspective AI model achieves high accuracy in early lung cancer diagnosis (0 replies)
  210. New ruthenium-based active agent enables cancer treatment in oxygen-depleted tumors (0 replies)
  211. World Health Day 2026: WHO urges global collaboration and science for better health (0 replies)
  212. New 3D printing method delivers cancer drugs directly to tumors (0 replies)
  213. New technique can simultaneously treat lung cancer and muscle-wasting condition (0 replies)
  214. New target identified to overcome resistance in neuroendocrine tumors (0 replies)
  215. Princeton researchers reveal new links between high-fat diets and aggressive breast c (0 replies)
  216. Study finds increasing rates of therapy-related acute myeloid leukemia (0 replies)
  217. Study finds gaps in preventive care for women with diabetes (0 replies)
  218. Advances in nanomedicine improve anthelmintic drug delivery and effectiveness (0 replies)
  219. Oral molecule prevents kidney stones and restores survival in mice (0 replies)
  220. NCCN grants funding to five oncology leaders of the future (0 replies)
  221. Trump?s one big beautiful bill act darkens outlook for government-backed clinics (0 replies)
  222. Innate immunity genes may influence earlier breast cancer onset in BRCA1 carriers (0 replies)
  223. Aging reshapes breast tissue creating environment favorable for cancer (0 replies)
  224. Study reveals how extracellular matrix stiffness regulates breast cancer metastasis (0 replies)
  225. Circulating tumor DNA predicts breast cancer relapse after treatment (0 replies)
  226. Machine learning model predicts liver cancer risk with high accuracy (0 replies)
  227. Breast cancer cells exploit the lung's repair system to support tumor growth (0 replies)
  228. Breast cancer patients may avoid lymphedema with radiotherapy approach (0 replies)
  229. Cancer-fighting antibodies may trigger autoimmune brain disorders (0 replies)
  230. New approach helps immune cells find and attack solid tumors (0 replies)
  231. Polyurethane-coated implants may reduce scarring after breast reconstruction surgery (0 replies)
  232. Personalized radiotherapy reduces the risk of breast cancer recurrence (0 replies)
  233. Blood-based test helps personalize breast cancer care for older patients (0 replies)
  234. New mechanism drives adverse tumor remodeling during breast cancer progression (0 replies)
  235. Cancer cells rely on glutathione as fuel for growth (0 replies)
  236. Combination therapy shows promise for leptomeningeal metastasis in breast cancer (0 replies)
  237. Reducing lung cell lipid production decreases metastatic tumor spread (0 replies)
  238. Engineered bacteria may improve precision cancer drug delivery (0 replies)
  239. Exercise cuts 'chemo brain' and fatigue in cancer patients (0 replies)
  240. Researchers develop targeted delivery system for poorly soluble cancer drugs (0 replies)
  241. Transforming prostate screening into a global gold standard (0 replies)
  242. Combined CDK4/6 and EGFR inhibition improves pancreatic cancer therapy (0 replies)
  243. Researchers achieve breakthrough in the production of vital chemotherapy agent (0 replies)
  244. Fertility treatments linked to small increases in some cancers (0 replies)
  245. Study identifies immune cells and RANK protein as fertility regulators (0 replies)
  246. Structured exercise helps chemotherapy patients maintain cognitive function and menta (0 replies)
  247. VALANX Biotech secures ?3 million to advance LIV-1 ADC for metastatic triple-negative (0 replies)
  248. Dual-positive hybrid cells linked to shorter survival in advanced breast cancer (0 replies)
  249. Geographic location strongly influences stage of breast cancer diagnosis (0 replies)
  250. Alginate-enhanced gel improves organoid development (0 replies)